VEGF-targeted therapy: mechanisms of anti-tumour activity

@article{Ellis2008VEGFtargetedTM,
  title={VEGF-targeted therapy: mechanisms of anti-tumour activity},
  author={Lee M. Ellis and Daniel J. Hicklin},
  journal={Nature Reviews Cancer},
  year={2008},
  volume={8},
  pages={579-591}
}
Several vascular endothelial growth factor (VEGF)-targeted agents, administered either as single agents or in combination with chemotherapy, have been shown to benefit patients with advanced-stage malignancies. VEGF-targeted therapies were initially developed with the notion that they would inhibit new blood vessel growth and thus starve tumours of necessary oxygen and nutrients. It has become increasingly apparent, however, that the therapeutic benefit associated with VEGF-targeted therapy is… CONTINUE READING
Highly Influential
This paper has highly influenced 33 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 638 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 108 references

A quantitative analysis of kinase inhibitor selectivity

  • T. Choueiri
  • Nature Biotechnol .
  • 2008

Mechanistic evaluation of the combination effect of anti - VEGF and chemotherapy [ abstract ]

  • I. Kasman
  • Proc . Am . Assoc . Cancer Res . Annu . Meeting
  • 2008

Neuropilin - 1 and neuropilin - 2 act as coreceptors , potentiating proangiogenic activity

  • E. Sulpice
  • Blood
  • 2008

Similar Papers

Loading similar papers…